1. Home
  2. BCAB vs INTG Comparison

BCAB vs INTG Comparison

Compare BCAB & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • INTG
  • Stock Information
  • Founded
  • BCAB 2007
  • INTG 1965
  • Country
  • BCAB United States
  • INTG United States
  • Employees
  • BCAB N/A
  • INTG N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • INTG Building operators
  • Sector
  • BCAB Health Care
  • INTG Real Estate
  • Exchange
  • BCAB Nasdaq
  • INTG Nasdaq
  • Market Cap
  • BCAB 40.5M
  • INTG 38.9M
  • IPO Year
  • BCAB 2020
  • INTG N/A
  • Fundamental
  • Price
  • BCAB $0.76
  • INTG $41.07
  • Analyst Decision
  • BCAB Hold
  • INTG
  • Analyst Count
  • BCAB 3
  • INTG 0
  • Target Price
  • BCAB $1.00
  • INTG N/A
  • AVG Volume (30 Days)
  • BCAB 1.4M
  • INTG 12.5K
  • Earning Date
  • BCAB 11-05-2025
  • INTG 11-12-2025
  • Dividend Yield
  • BCAB N/A
  • INTG N/A
  • EPS Growth
  • BCAB N/A
  • INTG N/A
  • EPS
  • BCAB N/A
  • INTG N/A
  • Revenue
  • BCAB $11,000,000.00
  • INTG $64,378,000.00
  • Revenue This Year
  • BCAB N/A
  • INTG N/A
  • Revenue Next Year
  • BCAB N/A
  • INTG N/A
  • P/E Ratio
  • BCAB N/A
  • INTG N/A
  • Revenue Growth
  • BCAB N/A
  • INTG 10.73
  • 52 Week Low
  • BCAB $0.24
  • INTG $9.57
  • 52 Week High
  • BCAB $2.53
  • INTG $42.50
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 52.28
  • INTG 84.78
  • Support Level
  • BCAB $0.61
  • INTG $27.11
  • Resistance Level
  • BCAB $1.06
  • INTG $32.00
  • Average True Range (ATR)
  • BCAB 0.13
  • INTG 5.59
  • MACD
  • BCAB -0.02
  • INTG 1.72
  • Stochastic Oscillator
  • BCAB 32.78
  • INTG 97.17

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

Share on Social Networks: